Stock Price Quote

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE468.752.35 (+0.5 %)
PREV CLOSE ( ) 466.40
OPEN PRICE ( ) 468.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 136945
TODAY'S LOW / HIGH ( )460.45 474.00
52 WK LOW / HIGH ( )168 572.7
NSE468.902.6 (+0.56 %)
PREV CLOSE( ) 466.30
OPEN PRICE ( ) 470.00
BID PRICE (QTY) 468.90 (503)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2161218
TODAY'S LOW / HIGH( ) 460.40 474.00
52 WK LOW / HIGH ( )161.65 573.05
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

26Nov Glenmark secures position in Dow Jones
Glenmark Pharmaceuticals has been listed in the Dow Jones Sustainability..
26Nov Glenmark Pharma gains on the bourses
Glenmark Pharmaceuticals is currently trading at Rs. 469.35, up by 2.95..
23Nov Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that it enclosed media release tit..
11Nov Glenmark Pharmaceuticals’ arm gets USF
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..
11Nov Glenmark Pharmaceuticals rises as its
Glenmark Pharmaceuticals is currently trading at Rs. 479.90, up by 5.35..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit4028.7613545.48
Gross Profit 4615.53 15346.44
Operating Profit 5587.5919110.18
Net Sales 20621.6567126.31

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  4898.80 (1.92%)
M.Cap ( in Cr)81459.69
Divis Lab (BSE)
peergroup  3545.35 (2.09%)
M.Cap ( in Cr)94117.90
Gland Pharma (BSE)
peergroup  2108.95 (2.65%)
M.Cap ( in Cr)34435.53
Wockhardt (BSE)
peergroup  434.10 (10.00%)
M.Cap ( in Cr)4807.96
Piramal Enterprises (BSE)
peergroup  1423.15 (2.47%)
M.Cap ( in Cr)32097.48

Shareholding Pattern

PROMOTERS 46.63%
MUTUAL FUNDS/UTI 3.56%
NON-INSTITUTION 23.13%
FI/BANKS/INSURANCE 0.83%
GOVERNMENT 0%
FII 0%

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 466.4. Its current market capitalisation stands at Rs 13226.63 Cr. In the latest quarter, company has reported Gross Sales of Rs. 106409.69 Cr and Total Income of Rs.108005.71 Cr. The company's management includes Dipankar Bhattacharjee, Saira Ramasastry, D R Mehta, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)